002872 Tiansheng Pharmaceutical Group
- 3.60
- +0.11+3.15%
Tiansheng Pharmaceutical Group News
ST Tiansheng (002872.SZ) announced first-quarter results with a net loss of 20.46 million yuan
According to the Zhitong Finance App, ST Tiansheng (002872.SZ) disclosed its report for the first quarter of 2024. During the reporting period, the company achieved revenue of 148 million yuan, a year-on-year decrease of 5.98%; a net profit loss of 20.46 million yuan to mother; and a loss of 22.36 million yuan in non-net profit. Basic earnings per share - $0.0643.
ST Tiansheng (002872.SZ): Expected net loss of 75 million yuan to 105 million yuan in 2023
Gelonghui, January 30 | ST Tiansheng (002872.SZ) announced that it is expected to have a net loss of 75.0 million yuan to 10,500,000 yuan in 2023, after deducting non-net loss of 95.0 million yuan to 130.0 million yuan, and operating income of 520.00 million yuan to 615.00 million yuan. The main reason for the loss in the company's performance during the reporting period was insufficient capacity utilization of the new production line and high fixed costs such as depreciation of fixed assets and labor costs.
The controlling shareholder of ST Tiansheng (002872.SZ) has released all of its pledged shares
ST Tiansheng (002872.SZ) issued an announcement. The company recently inquired about China Securities Registration and Settlement Co., Ltd...
ST Tiansheng (002872.SZ): Currently, some products have been transferred to the new workshop for production, and other varieties are still being transferred
Gelonghui November 17丨ST Tiansheng (002872.SZ) held a performance briefing on November 17, 2023, on “When will all of the new smart factories be relocated?” The company replied that with the gradual commissioning of smart factories, at present, some products have been transferred to new workshops for production, while other varieties are still being transferred.
ST Tiansheng (002872.SZ): Acetaminophen tablets passed generic drug consistency evaluation
ST Tiansheng (002872.SZ) issued an announcement. The company recently received approval from the State Drug Administration...
ST Tiansheng (002872.SZ): There are currently no weight loss products on sale
Glonghui, October 17丨ST Tiansheng (002872.SZ) said on the investor interactive platform that the company currently has no weight loss products for sale. The company's pharmaceutical products mainly cover the fields of pediatrics, gynecology, cardiovascular system, digestive system, orthopedics, respiratory medicine, anti-infective treatment, cardiovascular and cerebrovascular diseases.
ST Tiansheng (002872.SZ) Financial Director Wang Kaisheng completed a holdings reduction of 43,000 shares
According to the Zhitong Finance App, ST Tiansheng (002872.SZ) announced that Wang Kaisheng, the company's financial director, has reduced the company's holdings by a total of 43,000 shares. The implementation of this holdings reduction plan has been completed.
Tiansheng Pharmaceutical's Technology Center Named National Enterprise Technology Center
03:21 AM EST, 02/24/2023 (MT Newswires) -- Tiansheng Pharmaceutical Group's (SHE:002872) technology center has been recognized as a National Enterprise Technology Center by various government departme
Tiansheng Pharmaceutical Unit Gets Regulatory Approval for Injection
06:06 AM EST, 11/18/2022 (MT Newswires) -- Tiansheng Pharmaceutical Group (SHE:002872) unit Hubei Tiansheng Pharmaceutical received approval from the National Medical Products Administration for the r
KuaiBao: ST Tiansheng (002872) blocked the falling limit at 11:04 on January 18th.
On January 18, intraday news, 11:04 ST Tiansheng (002872) closed the limit. The current price is 5.43, down 4.57%. The pharmaceutical business in the sector to which it belongs is currently down. Lead the stock for Seri Medical. The main indicators and industry rankings of ST Tiansheng are as follows: ST Tiansheng (002872) stock profile: this article is compiled by Securities Star data Center according to public data, and does not constitute investment opinions or suggestions. If you have any questions, please contact us.
News flash: ST Tiansheng fell by the daily limit at 5.41 yuan.
China Finance Online Co Ltd news, today ST Tiansheng opened at 5.65 yuan, as of 10:30, the stock fell 4.92% to 5.41 yuan, sealed the limit. Yesterday (2022-01-17) the net outflow of the stock was-6.0878 million yuan, the main net outflow was-5.1657 million yuan, the net inflow of the single unit was 456200 yuan, and the net outflow of retail investors was-1.3783 million yuan. (to view real-time capital flows, please click) in the last month, ST Tiansheng has been on the Dragon and Tiger list for a total of 0 times, indicating that ST Tiansheng shares are sexually inactive. (for more enquiries on the Dragon and Tiger list
News flash: ST Tiansheng trading at 5.78 yuan
China Finance Online Co Ltd news, today ST Tiansheng opened at 5.47 yuan, as of 13:10, the stock rose 5.09% to 5.78 yuan, sealed the limit. Yesterday (2022-01-13) the net outflow of the stock was-2.4679 million yuan, the main net outflow was-1.2722 million yuan, the net outflow of the single unit was-231700 yuan, and the net outflow of retail investors was-963900 yuan. (to view real-time capital flows, please click) in the last month, ST Tiansheng has been on the Dragon and Tiger list for a total of 0 times, indicating that ST Tiansheng shares are sexually inactive. (for more enquiries on the Dragon and Tiger list
KuaiBao: ST Tiansheng (002872) blocked the trading limit at 13:09 on January 14.
On January 14, intraday news, 13:09 ST Tiansheng (002872) sealed the trading limit. The current price is 5.78, up 5.09%. The pharmaceutical business in the sector to which it belongs is currently on the rise. The leading stock is to open an industry. The main indicators and industry rankings of ST Tiansheng are as follows: ST Tiansheng (002872) stock profile: this article is compiled by Securities Star data Center according to public data, and does not constitute investment opinions or suggestions. If you have any questions, please contact us.
News flash: ST Tiansheng trading at 5.62 yuan
China Finance Online Co Ltd net on January 5 news, today ST Tiansheng opened at 5.42 yuan, as of 10:25, the stock rose 5.05% to 5.62 yuan, sealed the limit. Yesterday (2022-01-04) the net inflow of the stock was 5.829 million yuan, the main net inflow was 2.6035 million yuan, the net inflow of China alone was 1.9105 million yuan, and the net inflow of retail investors was 1.3149 million yuan. (to view real-time capital flows, please click) in the last month, ST Tiansheng has been on the Dragon and Tiger list for a total of 0 times, indicating that ST Tiansheng shares are sexually inactive. (for more enquiries on the Dragon and Tiger list, please click)
KuaiBao: ST Tiansheng (002872) blocked the trading limit at 10:28 on January 5th.
On January 5, intraday news, 10:28 ST Tiansheng (002872) sealed the trading limit. The current price is 5.62, up 5.05%. The pharmaceutical business in the sector to which it belongs is currently down. Lead the stock for Baiyang Pharmaceutical. The main indicators and industry rankings of ST Tiansheng are as follows: ST Tiansheng (002872) stock profile: this article is compiled by Securities Star data Center according to public data, and does not constitute investment opinions or suggestions. If you have any questions, please contact us.
KuaiBao: ST Tiansheng (002872) sealed the trading limit at 14:44 on December 31st.
On December 31, intraday news, 14:44 ST Tiansheng (002872) sealed the trading limit. The current price is 5.23, up 5.02%. The pharmaceutical business in the sector to which it belongs is currently on the rise. The leading stock is to open an industry. The main indicators and industry rankings of ST Tiansheng are as follows: ST Tiansheng (002872) stock profile: this article is compiled by Securities Star data Center according to public data, and does not constitute investment opinions or suggestions. If you have any questions, please contact us.
News flash: ST Tiansheng trading at 5.23 yuan
China Finance Online Co Ltd net December 31 news, today ST Tiansheng opened at 5.03 yuan, as of 09:45, the stock rose 5.02% to 5.23 yuan, sealed the limit. Yesterday (2021-12-30) the net outflow of the stock was-599300 yuan, the main net outflow was 0 yuan, the single net outflow was-594600 yuan, and the net outflow of retail investors was-4730.01 yuan. (to view real-time capital flows, please click) in the last month, ST Tiansheng has been on the Dragon and Tiger list for a total of 0 times, indicating that ST Tiansheng shares are sexually inactive. (for more enquiries on the Dragon and Tiger list, please click)
ST Tiansheng's latest announcement: plans to rehire Beijing Xinghua Accounting firm
ST Tiansheng announcement, the company held the seventh meeting of the Fifth session of the Board of Directors and the sixth meeting of the Fifth Board of Supervisors on November 22, 2021, which examined and passed the "proposal on the re-employment of the Company's 2021 Audit institutions" and agreed to continue to employ Beijing Xinghua Accounting firm (Special General Partnership) as the company's 2021 audit institution for a period of one year. According to the third quarterly report of ST Tiansheng 2021, the company's main income was 602 million yuan, down 33.14% from the same period last year; the net profit was-67.8365 million yuan, up 43.14% from the same period last year; and deducting non-net profit-85.9833 million yuan
ST Tiansheng (002872.SZ): plans to rehire Beijing Xinghua Accounting firm
ST Tiansheng (002872.SZ) announced that the company held the seventh meeting of the Fifth session of the Board of Directors and the sixth meeting of the Fifth Board of Supervisors on November 22, 2021, which examined and passed the "motion on the re-employment of the company's 2021 audit institution" and agreed to continue to employ Beijing Xinghua accounting firm (special general partnership) as the company's 2021 audit institution for a period of one year.
ST Tiansheng (002872.SZ) provides financial assistance of no more than 147 million yuan to Changsheng Pharmaceutical, a shareholding company.
Zhitong Financial App, ST Tiansheng (002872.SZ) issued a notice that Chongqing Pharmaceutical Group Changsheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Changsheng Pharmaceutical") is a shareholding company of Tiansheng Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the company" or "Tiansheng Pharmaceutical"), in order to meet the daily business development needs of Changsheng Pharmaceutical. The company intends to use its own funds to provide financial assistance of no more than 147 million yuan according to the 49% shareholding ratio of Changsheng Pharmaceuticals. The subsidy period is one year, and the interest is calculated at the annual interest rate of 4%. Chongqing Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "Chongqing Pharmaceutical"), the controlling shareholder of Changsheng Pharmaceutical.
Analysis
Price Target
No Data
